Beneficial ownership — 13D / 13G
87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | WKSP Worksport Ltd | 13G/A | 4.99% | Mar 31, 2026 | 6mo |
| Nantahala Capital Management, LLC | COCH Envoy Medical, Inc. | 13G | 9.99% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | AZ A2z Cust2mate Solutions Corp. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| Point72 Asset Management, L.P. | KALV KalVista Pharmaceuticals, Inc. | 13G/A | 4.2% | Mar 31, 2026 | 6mo |
| Sirenia Capital Management LP | PTN Palatin Technologies Inc | 13G | 9.9% | Mar 31, 2026 | 6mo |
| TCI FUND MANAGEMENT LTD | MCO Moodys Corp | 13G/A | 8.21% | Mar 31, 2026 | 6mo |
| North Reef Capital Management LP | STEL Stellar Bancorp, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | TW Tradeweb Markets Inc. | 13G/A | 6.5% | Mar 31, 2026 | 6mo |
| Trails Edge Capital Partners, LP | IKT Inhibikase Therapeutics, Inc. | 13G/A | 6.1% | Mar 31, 2026 | 6mo |
| JANUS HENDERSON GROUP PLC | FBRX Forte Biosciences, Inc. | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| PERCEPTIVE ADVISORS LLC | TENX Tenax Therapeutics, Inc. | 13G/A | 5.5% | Mar 31, 2026 | 6mo |
| Woodline Partners LP | VSH Vishay Intertechnology Inc | 13G/A | 4% | Mar 31, 2026 | 6mo |
| Westchester Capital Management, LLC | CRAC Crown Reserve Acquisition Corp. I | 13G | 5.09% | Mar 31, 2026 | 6mo |
| Iroquois Capital Management, LLC | WORX SCWorx Corp. | 13G/A | 9.6% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | BATL Battalion Oil Corp | 13G | 9.99% | Mar 31, 2026 | 6mo |
| Darsana Capital Partners LP | WMG Warner Music Group Corp. | 13G/A | 8.1% | Mar 31, 2026 | 6mo |
| Woodline Partners LP | ACET Adicet Bio, Inc. | 13G/A | 3.3% | Mar 31, 2026 | 6mo |
| ORION RESOURCE PARTNERS (USA) LP | IAUX i-80 Gold Corp. | 13G/A | 2.6% | Mar 31, 2026 | 6mo |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | XFLH XFLH Capital Corp | 13G | 6.8% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | SKY Champion Homes, Inc. | 13G/A | 6.8% | Mar 31, 2026 | 6mo |
| TENOR CAPITAL MANAGEMENT Co., L.P. | EGHA EGH Acquisition Corp. | 13G/A | 9.2% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | JBTM JBT MAREL Corp | 13G | 5.3% | Mar 31, 2026 | 6mo |
| AMERIPRISE FINANCIAL INC | TENB Tenable Holdings, Inc. | 13G/A | 7.4% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | GPGI GPGI, Inc. | 13G | 7.39% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | ENTG Entegris Inc | 13G/A | 7.7% | Mar 31, 2026 | 6mo |
| COHEN & STEERS, INC. | BXP BXP, Inc. | 13G/A | 13.19% | Mar 31, 2026 | 6mo |
| Point72 Asset Management, L.P. | IBIO iBio, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| Portolan Capital Management, LLC | QTRX Quanterix Corp | 13G/A | 6.25% | Mar 31, 2026 | 6mo |
| PERCEPTIVE ADVISORS LLC | RYTM Rhythm Pharmaceuticals, Inc. | 13G/A | 5.1% | Mar 31, 2026 | 6mo |
| AQR CAPITAL MANAGEMENT LLC | IT Gartner Inc | 13G | 5.06% | Mar 31, 2026 | 6mo |
| RPD Fund Management LLC | GTM ZoomInfo Technologies Inc. | 13G | 5.6% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | INVX Innovex International, Inc. | 13G | 5.3% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | IMUX Immunic, Inc. | 13G/A | 4.85% | Mar 31, 2026 | 6mo |
| Merus Global Investments, LLC | PELI Pelican Acquisition Corp | 13G/A | 0% | Mar 31, 2026 | 6mo |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | BXBL BOXABL Inc. | 13G/A | 6.8% | Mar 31, 2026 | 6mo |
| Nantahala Capital Management, LLC | IRD Opus Genetics, Inc. | 13G/A | 6.51% | Mar 31, 2026 | 6mo |
| Polar Asset Management Partners Inc. | DBCA D. Boral Acquisition I Corp. | 13G | 5.7% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | GT Goodyear Tire & Rubber Co | 13G/A | 6.9% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | PLMK Plum Acquisition Corp. IV | 13G | 6.22% | Mar 31, 2026 | 6mo |
| Pentwater Capital Management LP | EA Electronic Arts Inc. | 13G | 5.1% | Mar 31, 2026 | 6mo |
| RTW INVESTMENTS, LP | QURE uniQure N.V. | 13G/A | 4.1% | Mar 31, 2026 | 6mo |
| Venrock Healthcare Capital Partners III, L.P. | VOR Vor Biopharma Inc. | 13G/A | 9.9% | Mar 31, 2026 | 6mo |
| ROYAL BANK OF CANADA | WELPP Wisconsin Electric Power Co | 13G/A | 7.35% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | OFIX Orthofix Medical Inc. | 13G/A | 6.73% | Mar 31, 2026 | 6mo |
| Michael Kirban | COCO Vita Coco Company, Inc. | 13G/A | 5.6% | Mar 31, 2026 | 6mo |
| MAK Capital Fund LP | LAB Standard Biotools Inc. | 13G/A | 6.7% | Mar 31, 2026 | 6mo |
| PERCEPTIVE ADVISORS LLC | IKT Inhibikase Therapeutics, Inc. | 13G/A | 8.9% | Mar 31, 2026 | 6mo |
| SPROTT INC. | VZLA Vizsla Silver Corp. | 13G/A | 4.9% | Mar 31, 2026 | 6mo |
| JANUS HENDERSON GROUP PLC | BCAX Bicara Therapeutics Inc. | 13G | 5.1% | Mar 31, 2026 | 6mo |
| JANUS HENDERSON GROUP PLC | RVMD Revolution Medicines, Inc. | 13G/A | 4.9% | Mar 31, 2026 | 6mo |